Graves's most recent trade in Harrow Health Inc was a trade of 7,339 RSU done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 7,339 | 7,339 | - | - | RSU | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Paul W. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 2,082 | 2,082 | - | - | Stock Options (Right to Buy) | |
| 1st Source Corp. | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 60.83 per share. | 02 Jun 2025 | 1,606 | 19,342 (0%) | 0% | 60.8 | 97,693 | Common Stock |
| Charles River Labs | Paul W. Graves | Director | Grant, award, or other acquisition of securities at price $ 135.04 per share. | 02 Jun 2025 | 946 | 946 (0%) | 0% | 135.0 | 127,748 | Common Stock |
| Coherent Corp | Lisa Neal-Graves | Director | Sale of securities on an exchange or to another person at price $ 79.65 per share. | 28 May 2025 | 1,200 | 12,682 (0%) | 0% | 79.6 | 95,577 | Common Stock |
| Hamilton Insurance Group L... | Megan Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 21.02 per share. | 16 May 2025 | 25,000 | 204,674 | - | 21.0 | 525,500 | Class B Common Shares |
| Axcelis Technologies Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 3,586 | 7,258 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 19,592 | 32,086 (0%) | 0% | 0 | Common Stock | |
| Opus Genetics Inc. | Graves L. Adrienne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,592 | 79,592 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | Graves Adrienne L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,504 | 79,504 | - | 0 | Common Stock | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 14 Apr 2025 | 30,626 | 1,290,317 (1%) | 0% | 2.0 | 62,171 | Common Stock |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.07 per share. | 01 Apr 2025 | 247,933 | 1,320,943 (1%) | 0% | 2.1 | 513,221 | Common Stock |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 17 Mar 2025 | 18,772 | 1,073,010 (0%) | 0% | 2.7 | 51,435 | Common Stock |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 14 Mar 2025 | 53,256 | 229,674 | - | 20.1 | 1,068,315 | Class B Common Shares |
| SkyWater Technology Inc | Gregory B. Graves | Director | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 14 Mar 2025 | 12,844 | 14,285 | - | 8.1 | 104,165 | Common Stock |
| UMB Financial Corp. | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 110.29 per share. | 03 Mar 2025 | 255 | 37,288 (0%) | 0% | 110.3 | 28,125 | Common Stock |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 34,575 | 282,930 | - | 0 | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 29,319 | 248,355 | - | 0 | Class B Common Shares | |
| Coherent Corp | Lisa Neal-Graves | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Feb 2025 | 580 | 13,882 (0%) | 0% | 0 | Common Stock | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 24 Feb 2025 | 234,038 | 1,566,468 (1%) | 0% | 3.8 | 889,344 | Ordinary Shares |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 234,038 | 0 | - | - | Stock Option (Right to Buy) | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 24 Feb 2025 | 234,038 | 1,332,430 (0%) | 0% | 5.8 | 1,362,101 | Ordinary Shares |
| Mercury General Corp. | Christopher Graves | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 2,937 | 2,937 | - | - | Restricted Stock Unit | |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 668,731 | 1,332,430 (0%) | 0% | 0 | Ordinary Shares | |
| 1st Source Corp. | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 62.75 per share. | 03 Feb 2025 | 215 | 17,736 (0%) | 0% | 62.7 | 13,491 | Common Stock |
| UMB Financial Corp. | Gregory M. Graves | Director | Grant, award, or other acquisition of securities at price $ 117.90 per share. | 31 Jan 2025 | 678 | 36,922 (0%) | 0% | 117.9 | 79,936 | Common Stock |
| FirstCash Holdings Inc | James H. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 1,263 | 21,846 (0%) | 0% | 0 | Common Stock | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 18,076 | 175,151 | - | - | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 10,204 | 10,204 | - | - | 2023 LTIP - Restricted Stock Units | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 7,872 | 0 | - | - | 2022 LTIP - Restricted Stock Units | |
| AutoZone | G. Graves Earl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 90 | 5,048 (0%) | 0% | 0 | Common Stock | |
| Arcadium Lithium PLC | W. Graves Paul | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.97 per share. | 20 Dec 2024 | 91,941 | 663,699 (0%) | 0% | 5.0 | 456,947 | Ordinary Shares |
| 3D Systems Corp. | Graves Jeffrey A. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 17 Dec 2024 | 60,000 | 1,091,782 (0%) | 0% | 3.9 | 231,000 | Common Stock |
| Arcadium Lithium PLC | Paul W. Graves | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 11 Nov 2024 | 383,352 | 755,640 (0%) | 0% | 3.4 | 1,285,763 | Ordinary Shares |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 33,681 | 157,075 | - | - | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 33,681 | 33,681 | - | - | Restricted Stock Units | |
| UMB Financial Corp. | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 109.55 per share. | 01 Nov 2024 | 257 | 36,244 (0%) | 0% | 109.6 | 28,155 | Common Stock |
| 1st Source Corp. | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 60.94 per share. | 01 Nov 2024 | 221 | 17,521 (0%) | 0% | 60.9 | 13,468 | Common Stock |
| Opus Genetics Inc. | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 172,874 | 172,874 | - | - | Stock Option (right to buy) | |
| Thor Industries, Inc. | Andrew E. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 1,210 | 23,132 (0%) | 0% | 0 | Common Stock | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2024 | 247,933 | 1,031,782 (0%) | 0% | 0 | Common Stock | |
| Coherent Corp | Lisa Neal-Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 2,831 | 14,462 (0%) | 0% | 0 | Common Stock | |
| Heartland Financial USA, Inc. | Kathryn Graves Unger | Director | Sale of securities on an exchange or to another person at price $ 49.90 per share. | 02 Aug 2024 | 1,396 | 4,805 (0%) | 0% | 49.9 | 69,662 | Common Stock |
| UMB Financial Corp. | Gregory M. Graves | Director | Purchase of securities on an exchange or from another person at price $ 99.55 per share. | 01 Aug 2024 | 565 | 35,869 (0%) | 0% | 99.6 | 56,247 | Common Stock |
| 1st Source Corp. | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 64.41 per share. | 01 Aug 2024 | 85 | 17,300 (0%) | 0% | 64.4 | 5,475 | Common Stock |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64,564 | 64,564 | - | - | Stock Option (right to buy) | |
| Heartland Financial USA, Inc. | Kathryn Graves Unger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 4,805 | 0 | - | - | 2023 Restricted Stock Units | |
| Heartland Financial USA, Inc. | Kathryn Graves Unger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 4,805 | 6,201 (0%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 8,347 | 8,347 | - | - | RSU | |
| 1st Source Corp. | John F. Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 50.48 per share. | 03 Jun 2024 | 1,884 | 17,215 (0%) | 0% | 50.5 | 95,104 | Common Stock |
| SkyWater Technology Inc | Gregory B. Graves | Director | 22 May 2024 | 12,285 | 27,129 | - | 0 | Common Stock | ||
| SkyWater Technology Inc | Gregory B. Graves | Director | 21 May 2024 | 5,432 | 14,844 | - | 8.1 | 44,013 | Common Stock | |
| Heartland Financial USA, Inc. | Kathryn Graves Unger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 3,534 | 3,534 | - | - | 2024 Time-Based Restricted Stock | |
| Heartland Financial USA, Inc. | Kathryn Graves Unger | Director | Sale of securities on an exchange or to another person at price $ 45.59 per share. | 21 May 2024 | 2,450 | 1,396 (0%) | 0% | 45.6 | 111,694 | Common Stock |
| Axcelis Technologies Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 1,662 | 3,672 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,696 | 12,494 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,582 | 3,798 (0%) | 0% | 0 | Common Stock | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.53 per share. | 15 Apr 2024 | 30,752 | 783,849 (0%) | 0% | 3.5 | 108,555 | Common Stock |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.55 per share. | 15 Mar 2024 | 18,667 | 814,601 (0%) | 0% | 4.6 | 84,935 | Common Stock |
| Axcelis Technologies Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 1,340 | 1,340 (0%) | 0% | 0 | Common Stock | |
| Axcelis Technologies Inc | Gregory B. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 670 | 2,010 (0%) | 0% | 0 | Common Stock | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 32,552 | 32,552 | - | - | 2024 LTIP - Performance Stock Units | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 32,552 | 123,394 | - | - | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 6,020 | 0 | - | - | 2021 LTIP - Performance Stock Units | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2024 | 6,020 | 90,842 | - | - | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 31,033 | 84,822 | - | - | Class B Common Shares | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 12,957 | 0 | - | - | 2021 LTIP -Restricted Stock Units | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 10,204 | 20,408 | - | - | 2023 LTIP - Restricted Stock Units | |
| Hamilton Insurance Group L... | Graves | CEO, Hamilton Re | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 7,872 | 7,872 | - | - | 2022 LTIP - Restricted Stock Units | |
| UMB Financial Corp. | Gregory Graves M. | Director | Grant, award, or other acquisition of securities at price $ 82.22 per share. | 01 Feb 2024 | 851 | 35,027 (0%) | 0% | 82.2 | 69,969 | Common Stock |
| UMB Financial Corp. | M. Gregory Graves | Director | Purchase of securities on an exchange or from another person at price $ 81.87 per share. | 01 Feb 2024 | 284 | 34,176 (0%) | 0% | 81.9 | 23,251 | Common Stock |
| 1st Source Corp. | F. John Affleck-Graves | Director | Grant, award, or other acquisition of securities at price $ 54.68 per share. | 01 Feb 2024 | 246 | 15,331 (0%) | 0% | 54.7 | 13,451 | Common Stock |
| FirstCash Holdings Inc | Graves James H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 1,213 | 20,583 (0%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Adrienne Graves L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 3,119 | 3,119 | - | - | RSU | |
| 3D Systems Corp. | Graves A. Jeffrey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 158,622 | 910,597 (0%) | 0% | 0 | Common Stock | |
| 3D Systems Corp. | Jeffrey A. Graves | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 16 Jan 2024 | 77,329 | 833,268 (0%) | 0% | 4.9 | 375,819 | Common Stock |
| 3D Systems Corp. | Jeffrey Graves A. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.19 per share. | 12 Jan 2024 | 18,519 | 751,975 (0%) | 0% | 5.2 | 96,114 | Common Stock |
| Livent Corp | Paul W. Graves | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jan 2024 | 355,541 | 0 (0%) | 0% | - | Common Stock | |
| Livent Corp | Paul W. Graves | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jan 2024 | 200,512 | 0 | - | - | Stock Option (Right to Buy) | |
| Livent Corp | Graves Paul W. | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jan 2024 | 97,815 | 0 (0%) | 0% | - | Common Stock | |
| Livent Corp | Graves W. Paul | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jan 2024 | 60,628 | 0 | - | - | Stock Option (Right to Buy) | |
| Livent Corp | Paul W. Graves | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Jan 2024 | 59,653 | 0 | - | - | Stock Option (Right to Buy) | |
| AutoZone | Graves G. Earl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 125 | 4,957 (0%) | 0% | 0 | Common Stock | |
| Livent Corp | Graves W Paul | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 22,367 | 367,910 (0%) | 0% | 0 | Common Stock | |
| Livent Corp | Graves Paul W | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2023 | 20,414 | 356,832 (0%) | 0% | 0 | Common Stock | |
| Livent Corp | Graves W Paul | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.44 per share. | 22 Dec 2023 | 12,369 | 355,541 (0%) | 0% | 16.4 | 203,346 | Common Stock |
| Livent Corp | W Graves Paul | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.44 per share. | 22 Dec 2023 | 11,289 | 345,543 (0%) | 0% | 16.4 | 185,591 | Common Stock |
| Eagle Pharmaceuticals Inc | Michael Graves | Director, Interim Executive Chair & PEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 293,000 | 293,000 | - | - | Employee Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Graves Jeffrey A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 2,216 | 2,216 (0%) | 0% | 0 | Common Stock | |
| Thor Industries, Inc. | Andrew E. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 1,409 | 21,922 (0%) | 0% | 0 | Common Stock | |
| Hexcel Corp. | Jeffrey A. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 326 | 326 | - | - | Restricted Stock Units | |
| Livent Corp | Paul W Graves | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.49 per share. | 03 Oct 2023 | 71,303 | 395,662 (0%) | 0% | 10.5 | 747,968 | Common Stock |
| Livent Corp | Paul W Graves | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2023 | 71,303 | 0 | - | - | Stock Option (Right to Buy) | |
| Livent Corp | Paul W Graves | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.90 per share. | 03 Oct 2023 | 59,244 | 336,418 (0%) | 0% | 16.9 | 1,001,224 | Common Stock |
| Coherent Corp | Lisa Neal-Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 5,315 | 11,631 (0%) | 0% | 0 | Common Stock |